https://www.selleckchem.com/products/otx015.html
HEV clearance was observed after 34-42 days. Two patients, both treated with rituximab within the last 12 months before diagnosis of HEV infection, needed prolonged ribavirin therapy due to persistent viral ****tion. Reduction of daily dose of MPA therapy alone in transplant patients with chronic HEV infection may not be sufficient to control viral ****tion. HEV clearance under ribavirin therapy shows interindividual variability. Therefore, serial viral monitoring may be useful to personalize treatment duration. Rituximab therapy i
Like
Comment
Share
